Drug treatment for gum disease in people with Alzheimer’s
Part of Brain & nervous system, Mental health, Mouth & dental clinical trials.
This trial studies whether treating periodontal (gum) disease can help people who have probable Alzheimer’s disease. You may take a study treatment and have regular checks by a caregiver and study team.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Alzheimer’s dementia that doctors think is “probable,” based on standard diagnosis rules
- You can do a brain MRI scan during screening (or a CT scan only if MRI is unsafe for you)
- Your thinking tests show moderate ability to participate (MMSE score 15 or higher)
- You score low on a specific “brain blood vessel vs Alzheimer’s” checklist (Modified Hachinski score 4 or less)
- You have a willing primary caregiver who can help supervise treatment and check you through the study
- You have not had gum treatment or antibiotics in the past 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether treating gum disease can improve outcomes for people with Alzheimer's disease. If you have mild to moderate Alzheimer's and gum disease, you may be able to join.
This study looks at the bacteria in the mouth (periodontal microbiota) to see whether they differ between seniors with Alzheimer’s disease and seniors without it. You may be asked for a sample from your gums/teeth and background health information.
This trial tests a new medication, LHP588, for people with Alzheimer's who also have a common mouth bacteria called P. gingivalis. The goal is to see if targeting this bacteria can help slow down memory loss.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
This trial tests whether acupuncture can improve symptoms in people with Alzheimer’s disease. You may qualify if you have memory and thinking changes consistent with Alzheimer’s and meet imaging and brain-scan score requirements.
This study tests a sequence of treatments to see if they can help people with Alzheimer's disease or mild cognitive impairment. It aims to slow down memory decline and improve daily function.
Hear when a new Periodontitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.